Mitsubishi UFJ Morgan Stanley Securities’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$70.3K Sell
194
-337
-63% -$115K 0.21% 85
2026
Q1
$187K Sell
531
-235
-31% -$83.8K 0.46% 124
2025
Q4
$251K Buy
+766
New +$243K 0.39% 67
2014
Q4
$123K Hold
770
0.25% 19
2014
Q3
$108K Sell
770
-270
-26% -$35.3K 0.31% 21
2014
Q2
$123K Buy
1,040
+250
+32% +$28.9K 0.36% 16
2014
Q1
$97K Hold
790
0.26% 24
2013
Q4
$91K Buy
790
+80
+11% +$9.1K 0.15% 27
2013
Q3
$79K Hold
710
0.13% 29
2013
Q2
$70K Buy
+710
New +$73.7K 0.23% 38

Other funds holding AMGN

Mitsubishi UFJ Morgan Stanley Securities's AMGN Position: Q2 2026 in Review

Mitsubishi UFJ Morgan Stanley Securities reduced its Amgen (AMGN) stake by 63% in Q2 2026, selling an estimated $115K and leaving 194 shares worth $70.3K. The position accounts for 0.21% of the portfolio, ranked #85.

Mitsubishi UFJ Morgan Stanley Securities first reported a position in AMGN in Q2 2013 and has held it in 10 quarters since. The position peaked at $251K in Q4 2025. 1,219 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Mitsubishi UFJ Morgan Stanley Securities held 194 shares of Amgen worth $70.3K as of Q2 2026.
  • Mitsubishi UFJ Morgan Stanley Securities sold 337 Amgen shares in Q2 2026, an estimated $115K.
  • Amgen made up 0.21% of Mitsubishi UFJ Morgan Stanley Securities's portfolio in Q2 2026, its #85 holding.
  • Mitsubishi UFJ Morgan Stanley Securities first reported a position in Amgen in Q2 2013 and has held it in 10 quarters since.
  • Mitsubishi UFJ Morgan Stanley Securities's Amgen position peaked at $251K in Q4 2025.
  • 1,219 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Mitsubishi UFJ Morgan Stanley Securities's 13F filing for Q2 2026, filed 15 Jul 2026.